Page 4 - Best Brain MRI doctors in Istanbul: TOP 145 doctors

Education and Expertise

GATA Military Medical Faculty

GATA Haydarpaşa Training Hospital Neurosurgery Clinic (Specialization)

Beykent University Hospital and Health Institutions Management (Master's)

Experience

GATA Military Medical Faculty Trainee Doctor (6 months)

Samsun Sahara Medical School Comm. (3 months)

Naval Command War Squadron TCG Diligence Medical Officer (2 years)

Dz.K.K. Submarine Battery Factory Infirmary Doctor (3 months)

Naval Forces Command Infirmary Doctor (3 months)

GATA Haydarpaşa Training Hospital Chief Assistant (12 years)

Kasımpaşa Marine Hospital Neurosurgery Clinic Chief (5 years)

Bahçelievler Medical Park Hospital Neurosurgery Specialist (11 years)

Altınbaş University Faculty of Medicine Neurosurgery Lecturer. Member (4 years)

Altınbaş University Faculty of Medicine Head of Neurosurgery Department. (3 years)

Basic and Advanced Cardiac life support courses (BASIC)

Basic and Advanced Cardiac life support courses (ADVANCED)

GATA Military Medical Faculty. Microsurgery Training Course

Istanbul Vatan Hospital Hand surgery microsurgery course

Neuroanatomy course

Spine Surgery course

Professional Memberships

Turkish Neurosurgery Association

Spine Society of Europe

Turkish Spinal and Peripheral Nerve Surgery Group

Dr. Nurperi Gazioglu is a neurosurgeon. She trained at Istanbul University Cerrahpaşa Faculty of Medicine. She earned her MD in 1984 after study from 1978 to 1984. She completed neurosurgery training from 1986 to 1993. Her 1993 dissertation examined “Fetal Hypophysis Transplantation Under the Renal Capsule in Rats.”

She completed advanced courses in endoscopic pituitary surgery (2005, 2007, 2008) and endoscopic lumbar disc surgery (2007). She also trained in molecular genetics for clinicians (2003) and CME with the World Federation of Neurology (2002). She studied epilepsy surgery focused on insular–hippocampal anatomy (1999) and thoracolumbar trauma (1998). She attended the EANS European Neurosurgery Course (1988). Her clinical training includes observerships at APHP Necker–Enfants Malades and Hôpital Lariboisière in 1991. She completed an internship there in 1999.

Dr. Nihal Tastekin is a psychiatrist. She completed her residency in 2020 at Istanbul Erenköy Mental and Neurological Diseases Training and Research Hospital. She graduated from Pamukkale University Faculty of Medicine in 2013. Her thesis examined the clinical and cognitive effects of a computer-assisted cognitive improvement method in people with opioid use disorder.

She completed her state service at Bolu İzzet Baysal Mental Health and Diseases Hospital from October 2020 to June 2022. She provided AMATEM outpatient and inpatient care from April 2021 to June 2022. She has worked at the NP Istanbul Brain Hospital AMATEM clinic since June 2022.

Professional interests include addiction, anxiety disorders, cognitive remediation, dynamic psychotherapy, and cognitive behavioral therapy.

Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.

Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.

Dr. Inci Emekli is a neurologist at PARMER, Istanbul Medipol University (2025–). She specializes in Parkinson’s disease and movement disorders. She completed her neurology residency at Istanbul University (2015–2020). She then completed a neurology fellowship at Karabuk University (2020–2023) and movement disorders training at Michigan State University (2023–2024).

Her publications include an accepted article in Movement Disorders on the Head Snap Sign, a 2024 World Neurosurgery article on gender inequality in leadership, and a 2021 Parkinsonism & Related Disorders paper on hereditary Parkinson’s in Turkey. She delivered an oral presentation in 2022 on COVID‑19’s impact on carpal tunnel surgery. She also co‑authored a neurology chapter on hyperlipidemia in 2021.

Accreditation: Fellow of the Turkish Board of Neurology (2019–). Memberships: Turkish Society of Neurology (2016–) and European Academy of Neurology (2019–).

Dr. Buse Cagla Ari, MD, is an Associate Professor of Neurology. She specializes in Parkinson’s disease and other movement disorders, headache disorders, sleep disorders, and dementia. She works at Istanbul Medipol University and the Parkinson’s Disease and Movement Disorders Center (PARMER). She previously served as an Assistant Professor at Bahcesehir University.

Her research focuses on Parkinson’s disease biomarkers, cognition, uric acid and cholesterol associations, restless legs syndrome, and complex headaches. This includes a 13-patient case series. She has published 15 international and 4 Turkish papers and 5 book chapters. Her work has 147 citations on Google Scholar (h-index 5) and 91 citations on Web of Science (h-index 5).

She is a member of the International Parkinson and Movement Disorders Society, the International Headache Society, and the Turkish Parkinson’s Disease Society. She serves as a peer reviewer for SAGE Open Medical Case Reports, BMC Neurology, and Parkinsonism & Related Disorders.

The doctor is a highly skilled neurosurgeon with extensive experience in the field of brain and nerve surgery. Specializing in complex neurological disorders, the doctor has successfully performed numerous intricate surgeries, contributing significantly to advancements in neurosurgical techniques. The doctor is board-certified and has received multiple accolades for excellence in patient care and innovative research. With a commitment to education, the doctor frequently lectures at international conferences and has published extensively in peer-reviewed journals.

The doctor has extensive experience in occupational medicine, having worked in this field from 2013 to 2014. Prior to that, from 2005 to 2013, the doctor served at Haseki Education and Research Hospital, contributing significantly to the medical community. Additionally, from 1987 to 2013, the doctor was involved with Haliç University, working with the Foundation for Children with Leukemia, showcasing a long-standing commitment to pediatric oncology and research.

Prof. Dr. Yasef began his medical education at Istanbul University in 1973 and graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1979. He started his specialization in neurology at the same university in 1980 and became a neurologist in 1985. During his specialty training, he spent 6 months at Hacettepe University in the Neurology Department in Ankara.

After becoming a neurologist, he completed 3.5 years of obligatory government service, spending the first 1.5 years at the Iskenderun Navy Hospital and the next 2 years at Diyarbakır Social Security Hospital. He returned to Istanbul University in 1989.

Prof. Dr. Yasef worked abroad in the United States from 1990 - 1991, focusing on dementia and behavioral neurology.

In 1994, he became an Associate Professor and continued working at Istanbul University until 1999. Between 1999 - 2002, he worked at Florence Nightingale Hospital, and then at Kozyatağı Acıbadem Hospital from 2004 to 2013.

Since 2013, he has been a valuable part of the team at Florence Nightingale Hospital.

Specialties

• Dementia
• Epilepsy
• Headaches

Work Experience

• Military Service at Iskenderun Navy Hospital, 1985 - 1986
• State Service at Diyarbakır S.S.K. Hospital, 1986 - 1989
• Florence Nightingale Hospital, 1999 - 2002
• Kozyatağı Acıbadem Hospital, 2004 - 2013
• Florence Nightingale Hospital (Since 2013)

The doctor is a distinguished neurosurgeon with over twenty years of experience, specializing in general neurosurgery, endoscopic skull base and pituitary surgeries, as well as epilepsy and Parkinson's surgeries. His expertise extends to neurovascular, spine, spinal cord, nerve, and craniovertebral junction surgeries. The doctor is proficient in performing deep brain stimulation (DBS) surgeries.

He completed his medical education at Istanbul University and held significant roles in various hospitals, including serving as Chief of the Neurosurgery Department. He was appointed as an Associate Professor in 2013 and later achieved the title of Professor in 2020.

Dr Önul is FROM THE BEST DOCTORS in the field of Endoscopic skull base surgery and pituitary surgery Brain tumor surgery (Neuro Oncological surgery)


I was born in Artvin in 1977. He became a doctor from KTU Faculty of Medicine in 2001, and Bakırköy Prof. Dr. I became a Neurosurgery Specialist by getting the title of specialist from Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital. Again, in the same hospital, I was entitled to the title of associate professor in 2016. I continue to work at Başakşehir Çam and Sakura City Hospital, where I voluntarily joined with the task of establishing the Neurosurgery Clinic with my teammates. I am married and have 2 children. I love painting. I am very interested in children's literature. I have 10 printed children's tales

2015 - 2015

Medipol Üniversitesi Parkinson Hastalığı ve Hareket Bozuklukları Merkezi

2009 - 2009

Medicalpark Bahçelievler Hastanesi

1999 - 2004

Medicalpark Bahçelievler Hastanesi

1997 - 2009

Amerikan Hastanesi

1997 - 1997

VKV Amerikan Hastanesi

1995 - 1995

Division of Neurosurgery, Toronto Western Hospital Research Fellow

1995 - 1995

Department of Neurosurgery, The Johns Hopkins Hospital

1995 - 1997

Toronto Western Hospital,

1994 - 1994

Division of Neurosurgery, Toronto Western Hospital

1992 - 1992

Department of Neurosurgery, University of Virginia

1992 - 1992

Department of Neurosurgery, University of Washington

1992 - 1992

İsrail Kudüs, The European Association of Neurosurgical Societies European

1991 - 1991

İspanya Zaragoz- The European Association of Neurosurgical Societies European

1990 - 1990

Glasgow, Scotland, İngiltere

1990 - 1990

Glasgow ve Edinburg, The British Council

1990 - 1990

Glasgow ve Edinburg, The British Council1994

Marmara University Institute of Health Sciences, Neurophysiology

1993

Marmara University Faculty of Medicine, Neurosurgery and Neurosurgery

1989

Marmara University Faculty of Medicine, Neurosurgery and Neurosurgery

1983

Hacettepe University, Faculty of Medicine

1983

Hacettepe University, Faculty of Medicine

Education & Expertise

1996 to 2000 | Dicle University – Medical Education

Professional Experience

2001 to 2006 | Diyarbakır State Hospital – Neurology Specialist

2006 to 2009 | Düzce Atatürk State Hospital – Neurology Specialist

2009 to 2013 | Düzce University – Associate Professor of Neurology

2013 to 2016 | Düzce University – Associate Professor of Neurology

2017 to 2024 | Pendik Private Century Hospital – Associate Professor of Neurology

2024 to Present | VM Medical Park Pendik Hospital – Associate Professor of Neurology

Courses & Certifications

June, 2012 | Trainer Training Course

February, 2010 | Trainer Training Course

March, 2011 | Sleep Medicine Certification Program Preparation Course

December, 2012 | Sleep Disorders Diagnosis and Treatment Course

DBS Application Training and Course – Dubai

Professional Memberships

Turkish Medical Association

Turkish Neurology Association

Turkish Sleep Medicine Association

Awards & Recognitions

2014 | Düzce University Rectorship – Publication Success Incentive Award

Education & Academic Qualifications

License (MD)

Field: Medicine

University: Istanbul University

Year: 1987

Residency

Field: Cardiovascular Surgery

Institution: Siyami Ersek Heart Center

Years: 1988–1994

Clinical Fellowship

Field: Cardiovascular Surgery

Institution: University of Ottawa Heart Center (Canada)

Years: 1994–1995

Academic Titles & Positions

Assistant Professor

Field: Cardiovascular Surgery

Institution: Siyami Ersek Heart Center

Years: 1995–2008

Professor

Field: Cardiovascular Surgery

Institution: Altınbaş University

Years: 2014–2019

Membership in Scientific and Professional Organizations

-Turkish Society of Cardiovascular Surgery

-European Society for Cardiovascular Surgery

-European Society for Vascular Surgery

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. Halil Can is a Professor of Neurosurgery (2025; Associate Professor 2020). He completed neurosurgical training at Istanbul University–Istanbul Faculty of Medicine in 2007. His clinical focus includes endoscopic and microsurgical spine surgery for fractures, tumors, and degenerative disease; advanced pain procedures; endoscopic skull base and pituitary surgery; and neurovascular, neuro-oncologic, and peripheral nerve surgery.

He has 21 international peer-reviewed papers (SCI/SSCI). Topics include cadaveric morphometry of Kambin’s triangle and the transforaminal triangular working zone, lumbar arterial and anterior approach anatomy, and an in vitro test of a new lumbar fixation device.

His clinical studies include a single-team series of 81 posterior circulation aneurysms, with 13 flow-diversion cases. He also reported five spinal cavernous malformation cases. He conducted Phase I safety and feasibility stem-cell trials in pediatric hypoxic-ischemic encephalopathy and in chronic complete spinal cord injury.

Dr. Ali Osman Mucuoglu is a neurosurgeon. He completed his neurosurgery residency at Dokuz Eylül University from 2013 to 2019 after graduating from Eskişehir Osmangazi University in 2012 (2005–2012). He worked at Dokuz Eylül University and Muş State Hospital from 2019 to 2021. He has practiced at Atlas University Hospital since 2021.

He has five publications. These include a case report in the International Journal of Surgery Case Reports that has been cited seven times. He also reported on 3D printer‑assisted transsphenoidal hypophysectomy and on emergency minimally invasive intracerebral hemorrhage (ICH) surgery. He delivered an oral presentation at the 33rd Turkish Neurosurgical Society Congress in 2019.

He is a member of the Turkish Neurosurgical Society, the European Association of Neurosurgical Societies, and the Istanbul Chamber of Medicine. His advanced training includes spinal surgery courses in 2016 and 2017, the European Training Course on Head Injury and Functional Neurosurgery in 2017, and Surgical Neuroanatomy in 2017. He also holds an animal experimentation certificate from 2016.